2024 annual financial data
Seres Therapeutics 2024 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -121.32M USD and net income was -146.57M USD.
Operating cash flow was -148.61M USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -121.32M USD
- Net income
- -146.57M USD
- Operating cash flow
- -148.61M USD